ANTX
AN2 Therapeutics, Inc.
$4.42
-0.28 (-5.96%)
At close · Jul 2
Market Cap
$159.19M
Shares
36,016,161
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
63
Net buyers
-1
Net shares bought
0.00%
Net buy value
-$1,173
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-29 | Williams Sarah Joanne |
Principal Accounting Officer | Sell | 265 |
| 2026-04-10 | Marks Gilbert Lynn |
Director | Award | 3,775 |
| 2026-04-10 | Aziz Kabeer |
Director | Award | 3,775 |
| 2026-04-10 | Martin Patricia A. |
Director | Award | 1,192 |
| 2026-03-19 | Zakrzewski Joseph S |
Director | Award | 10,362 |
| 2026-03-19 | Chanda Sanjay |
Chief Development Officer | Award | 41,665 |
| 2026-03-19 | Easom Eric |
Director, Chief Executive Officer | Award | 267,650 |
| 2026-03-19 | Day Lucy |
Chief Financial Officer | Other | 82,300 |
| 2026-03-19 | Zakrzewski Joseph S |
Director | Award | 23,742 |
| 2026-03-19 | Spigelman Melvin K |
Director | Award | 10,362 |
| 2026-03-19 | Readnour Robin Shane |
Director | Other | 20,724 |
| 2026-03-19 | Chanda Sanjay |
Chief Development Officer | Other | 41,665 |
| 2026-03-19 | Wong Stephanie |
Director | Other | 23,742 |
| 2026-03-19 | Martin Patricia A. |
Director | Award | 24,999 |
| 2026-03-19 | Spigelman Melvin K |
Director | Award | 16,941 |
| 2026-03-19 | Wong Stephanie |
Director | Other | 10,362 |
| 2026-03-19 | Easom Eric |
Director, Chief Executive Officer | Award | 225,000 |
| 2026-03-19 | Marks Gilbert Lynn |
Director | Other | 10,362 |
| 2026-03-19 | Chanda Sanjay |
Chief Development Officer | Other | 57,950 |
| 2026-03-19 | Wong Stephanie |
Director | Award | 23,742 |
| 2026-03-19 | Zakrzewski Joseph S |
Director | Award | 99,999 |
| 2026-03-19 | Readnour Robin Shane |
Director | Award | 23,742 |
| 2026-03-19 | Easom Eric |
Director, Chief Executive Officer | Award | 249,999 |
| 2026-03-19 | Zakrzewski Joseph S |
Director | Other | 23,742 |
| 2026-03-19 | FitzPatrick Margaret M |
Director | Other | 23,742 |
| 2026-03-19 | Day Lucy |
Chief Financial Officer | Award | 73,665 |
| 2026-03-19 | Wong Stephanie |
Director | Other | 24,999 |
| 2026-03-19 | Chanda Sanjay |
Chief Development Officer | Award | 66,000 |
| 2026-03-19 | Aziz Kabeer |
Director | Other | 23,742 |
| 2026-03-19 | Zakrzewski Joseph S |
Director | Other | 99,999 |
| 2026-03-19 | Eizen Joshua M |
See Remarks | Other | 50,150 |
| 2026-03-19 | Marks Gilbert Lynn |
Director | Award | 10,362 |
| 2026-03-19 | FitzPatrick Margaret M |
Director | Award | 23,742 |
| 2026-03-19 | FitzPatrick Margaret M |
Director | Award | 10,362 |
| 2026-03-19 | Martin Patricia A. |
Director | Other | 24,999 |
| 2026-03-19 | Day Lucy |
Chief Financial Officer | Other | 66,000 |
| 2026-03-19 | Chanda Sanjay |
Chief Development Officer | Other | 66,000 |
| 2026-03-19 | Chanda Sanjay |
Chief Development Officer | Award | 57,950 |
| 2026-03-19 | Wong Stephanie |
Director | Award | 10,362 |
| 2026-03-19 | Readnour Robin Shane |
Director | Other | 23,742 |
| 2026-03-19 | Zakrzewski Joseph S |
Director | Other | 10,362 |
| 2026-03-19 | Easom Eric |
Director, Chief Executive Officer | Other | 249,999 |
| 2026-03-19 | Eizen Joshua M |
See Remarks | Other | 92,000 |
| 2026-03-19 | Easom Eric |
Director, Chief Executive Officer | Other | 225,000 |
| 2026-03-19 | Eizen Joshua M |
See Remarks | Award | 92,000 |
| 2026-03-19 | Aziz Kabeer |
Director | Award | 20,724 |
| 2026-03-19 | Spigelman Melvin K |
Director | Other | 23,742 |
| 2026-03-19 | Marks Gilbert Lynn |
Director | Award | 23,742 |
| 2026-03-19 | Marks Gilbert Lynn |
Director | Other | 23,742 |
| 2026-03-19 | Martin Patricia A. |
Director | Award | 23,742 |
Showing 1–50 of 345 transactions